Hanlon Investment Management’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,779	Closed	-$212K	–	189
2024 Q3	$212K	Buy	1,779 +330	+23%	+$39.3K	0.06%	162
2024 Q2	$207K	Buy	+1,449	New	+$207K	0.06%	155